Alaunos Therapeutics cuts stockholder meeting quorum requirement to one-third from majority
TCRT•Bylaws update reduces stockholder meeting quorum
Alaunos Therapeutics adopted second amended and restated bylaws, effective Sept. 16, 2026.
- Stockholder meeting quorum was cut to 33.33% of voting power from a majority of outstanding voting shares.
- Board and committee quorum remains a majority.
